Indication

Pinta

Pinta is a chronic, nonvenereal endemic treponematosis caused by the spirochete bacterium *Treponema carateum*. Read more about Pinta

4 drugs 3 manufacturers

Advertisement

Drugs that treat it

Common Pinta therapies.

Showing 1–4 of 4 drugs

Filter & compare in the drug finder →Opens the drug finder with Pinta preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Pinta.

Pinta is a chronic, nonvenereal endemic treponematosis caused by the spirochete bacterium *Treponema carateum*.

Primarily affecting the skin of children and young adults living in rural, impoverished regions of Central and South America, it is transmitted through direct skin-to-skin contact with infectious lesions.

Unlike other treponemal infections, pinta remains strictly confined to the dermis and epidermis without invading bone, cartilage, or internal viscera.

Clinically, the disease begins as pruritic erythematous papules or plaques (pintids) that slowly evolve over months to years into hyperpigmented, dyschromic patches, ultimately culminating in widespread, permanent hypopigmentation or achromia and epidermal atrophy.

Personalize your experience

Follow Pinta and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it